Collage photo ot Paolo Tarantino and Sara Tolaney
Mar 15, 2025, 18:15
Paolo Tarantino: Sara Tolaney on ongoing trials and controversies for ADCs in early breast cancer
Paolo Tarantino, Advanced Research Fellow at Dana-Farber Cancer Institute, shared a post on X:
“Will ADCs improve outcomes for early breast cancer?
Sara Tolaney reviews ongoing trials and controversies for ADCs in eBC, highlighting the need for careful patient selection (stage, biology, quantitative target expression), sequencing strategies and attention to toxicities.”
More posts featuring Paolo Tarantino.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 26, 2025, 00:17
Apr 25, 2025, 23:37
Apr 25, 2025, 19:33
Apr 25, 2025, 19:16
Apr 25, 2025, 19:06
Apr 25, 2025, 18:59